An AS04-containing human papillomavirus (HPV) 16/18 vaccine for prevention of cervical cancer is immunogenic and well-tolerated in women 15 - 55 years old. - Schwarz,T.F.; Dubin,G.O. (J Clin Oncol, 2006)